自 2021 年起，美国外科医生学会癌症委员会 (CoC) 认证标准要求为接受治疗的成人发病癌症患者提供生存计划。由于美国超过 70% 的癌症患者在 CoC 认可的机构接受治疗，这为对生存护理可用性进行景观分析提供了机会。为了确定 CoC 癌症生存服务的患病率、类型和结果，这项调查研究采用了 2023 年 5 月 4 日至 25 日进行的匿名在线横断面调查。参与者是美国 CoC 认证的机构，代表不同的 CoC 项目类别、机构特征、地理区域和实践类型。由于数据使用限制，退伍军人事务部癌症计划被排除在外。对 2023 年 7 月至 10 月的数据进行了分析。CoC 幸存者标准 4.8 于 2019 年 10 月发布，预计计划从 2021 年 1 月 1 日开始遵守该标准。问题包括自我报告的幸存者计划特征、符合 CoC 幸存者标准的服务的可用性4.8，以及感知到的计划影响。响应频率和比例是根据 CoC 项目类别总体确定的。共有 1400 个合格项目，384 个项目参与（27.4% 响应率）。所有地区和符合条件的计划类别都有代表，并且大多数在 2021 年的分析病例量为 500 至 4999 名患者。大多数生存计划人员包括护士（334 个项目 [87.0%]）和社会工作者（278 个项目 [72.4%]），而物理人员（180 个项目[46.9%]）和职业（87 个项目[22.7%]）治疗师不太常见。最受认可的适用于所有幸存者的服务包括新发癌症筛查（330 个项目 [87.5%]）、营养咨询（325 个项目 [85.3%]）和转诊至专家（320 个项目 [84.7%]），而治疗总结（ 242 个项目 [64.7%]）、幸存者护理计划（173 个项目 [43.0%]）、性健康（217 个项目 [57.3%]）和生育（214 个项目 [56.9%]）不太常见。幸存者服务通常由癌症治疗团队（243 个项目[63.3%]）而不是专门的幸存者诊所（120 个项目[31.3%]）提供。对于所需资源，最受认可的是致力于幸存者努力的额外高级临床医生（205 个项目[53.4%]）和电子健康记录增强功能（185 个项目[48.2%]）。缺乏转诊和患者意识低下被认为是主要障碍。共有 335 个项目 (87.2%) 同意幸存者标准 4.8 有助于推进他们的项目。这项 CoC 认证项目的调查研究结果为美国的幸存者护理服务建立了基准，确定了特定服务和干预机会方面的差距，有助于纵向重新评估以追踪全国进展情况，并提出幸存者护理标准的价值。

Since 2021, American College of Surgeons Commission on Cancer (CoC) accreditation standards require providing a survivorship program for patients with adult-onset cancer treated with curative intent. Since more than 70% of all patients with cancer in the US are treated at CoC-accredited facilities, this presents an opportunity for a landscape analysis of survivorship care availability.To determine the prevalence, types, and outcomes of cancer survivorship services at CoC-accredited facilities.This survey study used an anonymous, online, cross-sectional survey conducted from May 4 to 25, 2023. Participants were CoC-accredited facilities in the US representing diverse CoC program categories, institutional characteristics, geographic regions, and practice types. Department of Veterans Affairs cancer programs were excluded due to data usage restrictions. Data were analyzed from July to October 2023.CoC Survivorship Standard 4.8 was released in October 2019 and programs were expected to adhere to the Standard beginning January 1, 2021.Questions included self-reported survivorship program characteristics, availability of services aligned to CoC Survivorship Standard 4.8, and perceived program impacts. Response frequencies and proportions were determined in aggregate and by CoC program category.There were 1400 eligible programs, and 384 programs participated (27.4% response rate). All regions and eligible program categories were represented, and most had analytic caseloads of 500 to 4999 patients in 2021. Most survivorship program personnel included nurses (334 programs [87.0%]) and social workers (278 programs [72.4%]), while physical (180 programs [46.9%]) and occupational (87 programs [22.7%]) therapists were less common. Services most endorsed as available for all survivors were screening for new cancers (330 programs [87.5%]), nutritional counseling (325 programs [85.3%]), and referrals to specialists (320 programs [84.7%]), while treatment summaries (242 programs [64.7%]), and survivorship care plans (173 programs [43.0%]), sexual health (217 programs [57.3%]), and fertility (214 programs [56.9%]) were less common. Survivorship services were usually delivered by cancer treatment teams (243 programs [63.3%]) rather than specialized survivorship clinics (120 programs [31.3%]). For resources needed, additional advanced practice clinicians with dedicated survivorship effort (205 programs [53.4%]) and electronic health record enhancements (185 programs [48.2%]) were most endorsed. Lack of referrals and low patient awareness were endorsed as the primary barriers. A total of 335 programs (87.2%) agreed that Survivorship Standard 4.8 helped advance their programs.These findings of this survey study of CoC-accredited programs establish a benchmark for survivorship care delivery in the US, identify gaps in specific services and opportunities for intervention, contribute to longitudinal reevaluation for tracking progress nationally, and suggest the value of survivorship care standards.